Hepatitis E virus seroprevalence in pregnant women in Pakistan: maternal and fetal outcomes

被引:20
作者
Javed, Najma [1 ]
Ullah, Sultana H. [2 ]
Hussain, Nazli [2 ]
Sheikh, Munir A. [3 ]
Khan, Ambreen [4 ]
Ghafoor, Farkhanda [5 ]
Firdous, Rukhsana [6 ]
Uddin, Waqar [7 ]
Saqib, Arif N. [8 ]
Muhyudin, Ghazal [9 ]
机构
[1] Natl Inst Hlth, Islamabad, Pakistan
[2] Dow Med Univ, Karachi, Pakistan
[3] Liaqat Univ Med & Hlth Sci, Jamshoro, Pakistan
[4] Khyber Med Univ, Peshawar, Pakistan
[5] Sheikh Zyed Med Complex, Lahore, Pakistan
[6] Bolan Med Coll, Quetta, Pakistan
[7] Jinnah Post Grad Med Ctr, Karachi, Pakistan
[8] Pakistan Med Res Council, Islamabad, Pakistan
[9] Pakistan Med Res Council, Res Ctr, Faisalabad, Pakistan
基金
英国医学研究理事会;
关键词
NON-B-HEPATITIS; VIRAL-HEPATITIS; NON-A; INDIA; INFECTION; MORTALITY; ETIOLOGY; OUTBREAK; DISEASE;
D O I
10.26719/2017.23.8.559
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Hepatitis E virus (HEV) is endemic in Pakistan. Although otherwise asymptomatic, HEV infection becomes fatal in pregnancy, with considerable maternal and fetal morbidity and mortality. We conducted a descriptive study from April to October 2015 in 10 tertiary care hospitals throughout Pakistan to determine maternal and fetal morbidity and mortality in HEV-positive pregnant women with acute jaundice or raised liver function tests. Twenty-one of 135 women were HEV positive and in 3rd trimester except for 1 in 1st trimester. Overall prevalence of HEV in pregnancy was 0.19%. Ten women were artificially induced, 3 had premature labour, 4 delivered spontaneously (full term), 3 died and there was 1 intrauterine death. One woman had a home abortion before coming to hospital. There were 7 perinatal infant deaths: 4 intrauterine, 3 stillbirths and 1 abortion. Maternal mortality was significantly associated with delivery, as 17 mothers who lived went into labour spontaneously or were artificially induced, whereas 3 women who continued their pregnancy and did not deliver, died. Case fatality rate of HEV infection in pregnancy was 14.2%.
引用
收藏
页码:559 / 563
页数:5
相关论文
共 22 条
[21]  
WONG DC, 1980, LANCET, V2, P876
[22]   Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial [J].
Zhu, Feng-Cai ;
Zhang, Jun ;
Zhang, Xue-Feng ;
Zhou, Cheng ;
Wang, Zhong-Ze ;
Huang, Shou-Jie ;
Wang, Hua ;
Yang, Chang-Lin ;
Jiang, Han-Min ;
Cai, Jia-Ping ;
Wang, Yi-Jun ;
Ai, Xing ;
Hu, Yue-Mei ;
Tang, Quan ;
Yao, Xin ;
Yan, Qiang ;
Xian, Yang-Ling ;
Wu, Ting ;
Li, Yi-Min ;
Miao, Ji ;
Ng, Mun-Hon ;
Shih, James Wai-Kuo ;
Xia, Ning-Shao .
LANCET, 2010, 376 (9744) :895-902